Form 4: Nuvalent CLO Sells Shares After Option Exercise

Nuvalent's Chief Legal Officer, Deborah Ann Miller, exercised stock options and subsequently sold Class A Common Stock totaling 15,000 shares in pre-planned transactions.

Summary

• Deborah Ann Miller, Nuvalent, Inc.'s Chief Legal Officer, engaged in pre-planned transactions involving the company's Class A Common Stock.
• On January 21, 2026, Miller exercised options to acquire 700 shares at an exercise price of $27.85 per share and simultaneously sold these 700 shares at a weighted average price of $109.84 per share.
• On January 22, 2026, Miller exercised options to acquire an additional 14,300 shares at an exercise price of $27.85 per share and subsequently sold these 14,300 shares at a weighted average price of $110.16 per share.
• All transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Miller on November 18, 2024.
• Following these transactions, Miller's direct beneficial ownership of Class A Common Stock is 59,634 shares.

Sentiment

Score: 7

Explanation: The filing reports routine insider transactions (option exercise and sale) executed under a pre-arranged 10b5-1 trading plan, indicating planned activity rather than a reaction to new information. The significant difference between exercise and sale prices reflects a substantial gain for the officer, which is generally a neutral to slightly positive signal for the company's stock performance.

Positives

• The transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planned activity and transparency, rather than a reaction to new, non-public information.
• The significant difference between the option exercise price ($27.85) and the sale prices ($109.84 and $110.16) indicates a substantial realized gain for the reporting person.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived cautiously by the market, though the context of an option exercise and immediate sale under a 10b5-1 plan often mitigates this.

Future Outlook

This Form 4 filing reports past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing details routine insider stock transactions, which are common across all industries for executives managing their equity compensation. It does not provide specific insights into broader industry trends or competitive landscape.

Corporate Governance

Stakeholder Impact

• Shareholders: May note the insider selling, but the execution under a 10b5-1 plan typically mitigates concerns about opportunistic selling based on non-public information.
• Employees: The vesting schedule mentioned for the options highlights the company's equity compensation structure, which is a common incentive for key personnel.

Key Dates

Recommendation

The Form 4 details pre-scheduled insider transactions (option exercise and sale) by a Chief Legal Officer under a Rule 10b5-1 plan. While the officer realized significant gains, these are routine, planned transactions and do not inherently signal new positive or negative information about the company's future prospects. Therefore, a 'hold' recommendation is appropriate as this filing does not provide a basis for a change in investment thesis.

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Stock Options, Share Sale, 10b5-1 Plan, Chief Legal Officer